What Emka Technologies does

Emka Technologies (emka TECHNOLOGIES) is a French-headquartered (Lisses, France) provider of integrated preclinical physiological monitoring systems for pharmaceutical, biotechnology, contract research, government, and academic research organizations. Founded in 1991, the company builds hardware and software for in vivo, ex vivo, and in vitro studies covering cardiovascular, respiratory, and neurological endpoints, and reports an installed base of 7,600+ systems across 1,750+ institutions with reference users including Roche, Novartis, AstraZeneca, Merck, Boehringer Ingelheim, AbbVie, Regeneron, Charles River Laboratories, USAMRIID, Harvard, and Karolinska Institutet.

The product platform centers on IOX2 data acquisition software (GLP-compliant, handling up to 200 simultaneous signals) and ecgAUTO analysis software (proprietary shape-recognition-based ECG/arrhythmia/HRV analysis with 15+ years of proven use), supported by the easyTEL+ family of implantable digital telemetry transmitters (mice through large animals), the emkaPACK5 non-invasive jacket telemetry system, ecgTUNNEL non-invasive rodent ECG, emkaBATH tissue bath systems, the isolatedHEART Langendorff/Working Heart perfusion platform, and complementary modules for EEG, study design, data reduction, and audit management (EEG+, studyDESIGNER, datanalyst, auditCENTRAL). The platform integrates with third-party systems including Noldus EthoVision (behavioral tracking via easySYNC), National Instruments data acquisition, Transonic flowmeters, and DSI implants, and exports SEND 3.1 compliant data into Instem and Xybion preclinical platforms.

Emka monetizes through a mix of one-time hardware sales, one-time software licenses (with optional GLP/SEND modules), recurring Premium Care maintenance and support contracts, and professional services for installation, training, surgery, validation, and data analysis. Distribution is executed through a global distributor network combined with a direct enterprise sales motion staffed by application specialists who provide consultative solution specification, on-site installation, and training. Marketing relies on scientific conferences (ISHR, Safety Pharmacology Society, SOT), publications-database-driven credibility, a Knowledge Center content hub, hosted webinars, and a free custom literature search service. Emka also operates as a related company to SCIREQ, cross-referring respiratory and inhalation-exposure inquiries into SCIREQ's flexiVent, vivoFlow+, and inExpose product lines.

Name

Emka Technologies

Legal name

emka TECHNOLOGIES

Website

https://emkatech.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

Emka Technologies (Lisses, France) designs and sells integrated preclinical physiological monitoring systems—telemetry hardware, data-acquisition and ECG-analysis software, and tissue-bath/perfusion platforms—used by 1,750+ pharmaceutical, CRO, government, and academic research institutions for cardiovascular, respiratory, and neurological studies.

Ownership category

akta.pro rank

Product category

Preclinical Research Instrumentation

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Laboratory Analytical Instruments (3826), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

Keywords

• Preclinical research instrumentation
• Physiological monitoring systems
• Wireless animal telemetry
• Safety pharmacology equipment
• Cardiovascular analysis software

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Scientific Instrumentation Hardware: Sale of preclinical physiological monitoring equipment including telemetry systems (implantable and non-invasive), tissue bath systems, isolated heart perfusion systems, plethysmographs, and data loggers. Products are sold with associated sensors, transducers, and accessories.
2. Software Licenses and Subscriptions: IOX2 data acquisition software, ecgAUTO cardiovascular analysis software, and related modules (ecgAVG, EEG+, studyDESIGNER, datanalyst, auditCENTRAL) sold as licenses with optional GLP modules and SEND formatted exports.
3. Professional Services: Installation and training services, surgery training, validation services, and data analysis/reporting services including arrhythmia detection and study summaries.
4. Maintenance and Support Contracts: Premium Care Service maintenance agreements including unlimited technical support, on-demand training, annual preventive maintenance visits, software updates, and extended hardware warranty.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

emka TECHNOLOGIES designs, manufactures, and sells integrated hardware and software systems for preclinical physiological monitoring used in drug safety, pharmacology, toxicology, and basic biomedical research. The portfolio includes implantable and non-invasive wireless telemetry systems, ECG/respiratory analysis software with shape-recognition automation, tissue bath and isolated heart perfusion systems, and complementary data acquisition platforms, sold primarily to pharmaceutical, biotech, CRO, academic, and government research institutions worldwide.

Product overview

Emka Technologies provides a comprehensive portfolio of preclinical physiological monitoring solutions comprising both hardware systems and software platforms. The core offerings include IOX2 data acquisition software and ecgAUTO cardiovascular analysis software, which form the software backbone of the platform. Hardware products span in vivo telemetry systems (easyTEL+ implantable and emkaPACK5 jacket telemetry for rodents and large animals), non-invasive solutions (ecgTUNNEL for rodents, CODA for blood pressure), ex vivo systems (emkaBATH tissue baths, isolatedHEART perfusion systems), and respiratory equipment (flexiVent, vivoFlow+, inExpose). Add-on modules including ecgAVG, EEG+, datanalyst, studyDESIGNER, and auditCENTRAL extend functionality for specialized analysis, study management, and regulatory compliance. The platform integrates with third-party solutions including Noldus EthoVision for behavioral tracking, National Instruments data acquisition, and SEND-compliant data export to Instem and Xybion systems.

Differentiator

Problem solved

Functional benefit

Brands

• SCIREQ: Related brand for respiratory solutions and flexiVent pulmonary function measurement systems, operating at scireq.com

Products and services

• IOX2 Data Acquisition Software GLP-compliant physiological data acquisition software for acquiring, analyzing, viewing, and storing physiological data from emka hardware and third-party devices (Transonic flowmeters, DSI implants, National Instruments). Supports real-time analysis of up to 200 independent signals simultaneously and includes application-specific analysis modules for cardiovascular, respiratory, neurological, and electrophysiology data.
• ecgAUTO Software Cardiovascular analysis software using shape recognition techniques for ECG interval analysis, arrhythmia detection, heart rate variability, and blood pressure assessment across multiple species and leads. Optional GLP modules and SEND-formatted data export are available.
• easyTEL+ Digital Telemetry Range of biocompatible implantable digital telemetry transmitters for in vivo physiological monitoring in mice, rats, and large animals. Supports ECG, EEG, EMG, blood pressure, temperature, and activity signals from conscious, freely moving subjects, with wireless digital transmission and group housing up to 32 subjects.
• emkaPACK Jacket Telemetry Non-invasive jacket telemetry system for large animals (dogs, primates, swine, sheep, horses) acquiring ECG, respiratory endpoints, blood pressure, temperature, and postural activity from freely moving subjects without surgery or anesthesia.
• ecgTUNNEL Non-invasive ECG Plug-and-play non-invasive system for snapshot ECG recordings and respiration data in rodents, eliminating the need for surgery and anesthesia. Combines up to 6-lead ECG with optional plethysmograph dome for respiratory endpoints.
• CODA Non-invasive Blood Pressure System Non-invasive blood pressure measurement system for rodents using tail cuff methodology.
• emkaBATH Tissue Bath Systems Tissue bath setups (emkaBATH2 and emkaBATH4) for contractile measures in tissues including aortic, tracheal, iliac, and papillary muscles, and microvessels. Provides heated, oxygenated perfusate with optional drug administration and electrical stimulation.
• emkaMYO Myograph Systems Myograph systems for microvessel and tissue strip contraction measurements in vascular biology studies.
• isolatedHEART Perfusion System Isolated heart perfusion system supporting both Langendorff and Working Heart techniques for simultaneous assessment of cardiac electrophysiological and mechanical parameters including ECG, LVP, perfusion flow, and pressure.
• Perfusion Systems Organ perfusion systems for ex vivo studies including kidney and liver perfusion with integrated IOX software control.
• physioLens Automated microscopy and dosing platform for in vitro physiological studies.
• expoCube Cell exposure system for in vitro toxicology and drug testing applications.
• Data Loggers Data logging devices for continuous physiological parameter recording in preclinical studies.
• flexiVent Lung function phenotyping system for in vivo measurements of airway mechanics and pulmonary function in rodents.
• vivoFlow+ Whole Body Plethysmograph Whole body plethysmograph for non-invasive respiratory assessment in conscious animals, used in safety pharmacology and toxicology studies.
• inExpose Inhalation Exposure System Compact, customizable inhalation exposure system providing a reproducible method of exposing animals to test atmospheres for aerosol delivery studies.
• Anesthesia Systems Small animal anesthesia systems for preclinical research applications.
• Vital Sign Monitoring Vital sign monitoring equipment for continuous physiological parameter tracking.
• Surgical Platform Surgical platform for cardiovascular instrumentation procedures in preclinical research.
• usbACQ Signal Acquisition Device USB signal acquisition device supporting up to 4 synchronized analog channels with maximum sampling frequency of 2kHz per channel.
• easyMATRIX3 Signal Conditioning Device

Quantifiable outcome

• Several days of manual ECG analysis can be completed in approximately 30 minutes with ecgAUTO
• +3 more outcomes

Named customers17 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration7 records

AI capability2 records

Feature10 records

Partnerships

One partnership is on record.

• SCIREQcoreStrategic or Co-development PartnerEmka Technologies and SCIREQ operate as related companies offering complementary preclinical research solutions. While Emka focuses on cardiovascular and telemetry solutions, SCIREQ provides respiratory research products including flexiVent lung function systems, whole body plethysmographs, and inExpose inhalation exposure systems. The companies cross-reference each other's products and share resources.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• TSE Systems:
• ADInstruments: ADInstruments provides PowerLab data acquisition systems and LabChart software for life science research, including preclinical cardiovascular and respiratory applications. Competes directly with Emka's IOX2 and ecgAUTO across pharma, CROs, and academic labs.
• BIOPAC Systems: BIOPAC offers physiology data acquisition systems (MP160, BioNomadix) for preclinical cardiovascular, respiratory, and neurological research. Direct competitor to Emka's IOX2/ecgAUTO software stack with established academic and pharma channels.
• Data Sciences International (DSI): DSI (a Harvard Bioscience company) is the dominant incumbent in preclinical implantable telemetry for cardiovascular, respiratory, and neurological monitoring. Direct competitor to Emka's easyTEL+ product line with deeper pharma relationships, broader portfolio, and integration into IOX2 (Emka supports DSI implants).
• iWorx Systems: iWorx provides physiology teaching and research instrumentation including ECG, EMG, and cardiovascular monitoring systems used in academic and preclinical settings. Direct overlap with Emka's rodent ECG and cardiovascular product lines.

Broad incumbents

• Harvard Bioscience: Harvard Bioscience is the parent of DSI, TSE Systems, and other preclinical research brands. A broader public life science tools platform with portfolio companies directly competing with Emka in telemetry, behavioral, and metabolic research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/emka-technologies
• Xx.com/emkatech

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Emka Technologies